Get Started

MBRX

NASD Moleculin Biotech, Inc.
Nov 2, 2026 · 8:24 AM ET LAST TRADE Market Closed

$8.66 ↑ +0.76 (+9.63%) Trading Up from the previous close of $7.90

YTD change
-86.92%
vs 20-day SMA
+12.00%
vs 200-day SMA
-78.55%

Price ranges

Previous day
$7.90 $9.00
open $8.80 close $7.90
-$0.90 (-10.23%)
Today
$0.00 $0.00
$8.66
Past week
$6.50 $10.24
from $6.50 now $8.66
+$2.16 (+33.25%)
Past month
$4.42 $10.24
from $9.74 now $8.66
-$1.08 (-11.04%)
This year
$0.16 $66.20
from $66.20 now $8.66
-$57.54 (-86.92%)

Price & Performance

+5.42 (+218.55%) / 6M

$-0.4550$3.03$6.51$9.99May 4Aug 3Oct 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 100.0% away from all-time highs of $69,750.00
  • MBRX is down 87% since the beginning of the year
  • MBRX is down 96% over the past 12 months
  • MBRX is down 11% over the past 1 month
  • 20% of all MBRX investors are betting against MBRX

MBRX reads neutral: price sits above one of the two key moving averages, the 12-month move is +1420.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-28
Earnings momentum -215.8% Quarterly EPS growth
Quarterly change -215.8%

Valuation

P/E ratio 0.05
Enterprise value $-4726120.0
Beta 2.72

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$7.3M
Debt$292.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $8.8M

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe in July 2015 and is headquartered in Houston, TX.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $466.01 +1.15%
MRNA Moderna, Inc. $221.72 -0.47%
RVMD Revolution Medicines, Inc. $191.31 +0.55%
ROIV Roivant Sciences Ltd. $36.91 -1.63%
BNTX BioNTech SE Sponsored ADR $88.17 -1.08%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.